DOUGLAS HOLMES, M.D.
Retina Specialist (Ophthalmology) Physician · CASPER, WY
Individual Active NPI 1073565487
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,126 | 88,934 | $13,097,111 | $7,409,584 | $5,850,995 |
| 2023 | 1,098 | 44,865 | $9,047,689 | $5,289,517 | $4,158,341 |
| 2022 | 1,087 | 22,499 | $8,726,753 | $5,479,492 | $4,310,237 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 62,700 | $34 | $27 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 6,510 | $147 | $117 |
| 92134 | Imaging of retina | 4,422 | $41 | $32 |
| 92014 | Established patient complete exam of visual system | 3,872 | $128 | $93 |
| 67028 | Injection of drug into eye | 3,032 | $133 | $101 |
| J0178 | Injection, aflibercept, 1 mg | 2,584 | $827 | $659 |
| J2778 | Injection, ranibizumab, 0.1 mg | 1,850 | $161 | $128 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 1,220 | $108 | $86 |
| J0177 | Injection, aflibercept hd, 1 mg | 984 | $331 | $264 |
| J9035 | Injection, bevacizumab, 10 mg | 582 | $72 | $57 |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 460 | $172 | $137 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 224 | $168 | $121 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | ✓ | 8868A | WY |
| Specialist | 174400000X | 30384 | CO |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.